Low Catalytic Redox Activity of α-<i>N</i>-Pyridylthiosemicarbazone Iron Complexes Suggests an Indirect ROS Generation Mechanism in Their Biological Activity

α-<i>N</i>-Pyridylthiosemicarbazones (PTSC) are anticancer agents that can induce oxidative stress in cells, likely through interactions with metal ions. Redox-active Cu and Fe bind strongly to PTSC, forming complexes Cu-PTSC and Fe-PTSC₂. These complexes have been proposed to directly catalyze the formation of reactive oxygen species (ROS) and deplete key cellular reductants, thereby exerting oxidative stress. Alternatively, oxidative stress could also arise indirectly through interactions with other cellular targets. Evaluating catalytic rates could help distinguish direct from indirect mechanisms, as ROS production should outpace antioxidant defenses. In this respect, the catalytic activity of the Fe complexes of two PTSCs, Triapine (3AP) and Dp44mT, with the two most abundant reducing agents, ascorbate and glutathione, was evaluated under aerobic conditions. Fe-3AP₂ and Fe-Dp44mT₂ showed very low catalytic activity in depleting GSH/ascorbate and producing ROS (<4 turnovers per hour). Higher activity appeared with H₂O₂ and ascorbate, but only for 1:1 Fe-PTSC complexes, not 1:2 Fe-PTSC₂. Competition assays with H₂O₂-degrading enzyme catalase revealed that Fe-PTSC reacted 3 orders of magnitude slower than the enzyme. Thus, Fe-PTSC and Fe-PTSC₂ are unlikely to drive ROS production through a direct mechanism. Instead, an indirect mechanism or a site-specific ROS production appears to be more plausible.